Portal de investigación
- Inicio
- Proyectos y Estudios
- EFICACIA Y SEGURIDAD/TOLERABILIDAD DE VIEKIRAX Y EXVIERA EN PACIENTES DIAGNOSTICADOS DE VHC, COINFECTADOS O NO CON VIH-1, GT 1 O 4, Y ENFERMEDAD RENAL CRÓNICA EN ESTADIOS DE IIIB A V, INCLUYENDO AQUELLOS EN DIÁLISIS, EN PRÁCTICA CLÍNICA HABITUAL EN ESPAÑA . ESTUDIO VIE-KIND.
EFICACIA Y SEGURIDAD/TOLERABILIDAD DE VIEKIRAX Y EXVIERA EN PACIENTES DIAGNOSTICADOS DE VHC, COINFECTADOS O NO CON VIH-1, GT 1 O 4, Y ENFERMEDAD RENAL CRÓNICA EN ESTADIOS DE IIIB A V, INCLUYENDO AQUELLOS EN DIÁLISIS, EN PRÁCTICA CLÍNICA HABITUAL EN ESPAÑA . ESTUDIO VIE-KIND.
Datos básicos
- Protocolo:
- ABB-OMB-2015-01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- Año de finalización:
- 2016
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Diaz, FC; (...); Prieto, M
Article. 10.5604/16652681.1222114. 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study
Rodríguez-Nóvoa S; (...); Castro Á
Article. 10.1097/MCG.0000000000000569. 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles
Stephens, C; (...); Lucena, MI
Article. 10.1097/FPC.0000000000000230. 2016
Candidemia in major burns patients
ANA ISABEL RENAU ESCRIG; (...); Pemán J
Article. 10.1111/myc.12488. 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
Trickey, A; (...); Antiretroviral Therapy Cohort Coll
Article. 10.1371/journal.pone.0160460. 2016
Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality
Surez-Garcia, I; (...); del Amo, J
Article. 10.1111/add.13348. 2016
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
Lopez-Medrano, F; (...); STCS
Article. 10.1111/ajt.13837. 2016
Controlling Diabetes After Liver Transplantation: Room for Improvement
Alvarez-Sotomayor D; (...); Berenguer M
Article. 10.1097/TP.0000000000001399. 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
Fontana RJ; (...); Reddy KR
Article. 10.1002/lt.24416. 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I; (...); Spanish DILI Registry
Article. 10.1016/j.jhep.2016.05.003. 2016
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Belli LS; (...); European Liver and Intestine Association (ELITA)
Article. 10.1016/j.jhep.2016.05.010. 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
De Simone, P; (...); Samuel, D
Article. 10.1097/TP.0000000000001171. 2016
Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort
Sanchez Antolin G; (...); Castells L
Article. 10.1016/j.transproceed.2016.08.034. 2016
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
Forns X; (...); Van Solingen-Ristea R
Article. 2016
EPICO 3.0. Management of non-neutropenic patients in medical wards
Ferrer, R; (...); Huarte, R
Article. 10.1016/j.riam.2016.06.003. 2016
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics.
Berenguer, J; (...); Gonzalez-Garcia, J
Article. 10.1093/ofid/ofw059. 2016
Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation
Sáez-González E; (...); Berenguer M
Letter. 10.1038/ajg.2016.260. 2016
Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir
Rojas, J; (...); Martinez, E
Article. 10.1111/hiv.12314. 2016
Invasive fungal disease by Candida and other yeasts
Pemán J, Salavert M, Quindós G
Editorial Material. 10.1016/j.riam.2016.03.004. 2016
Invasive yeast infections in severely burned patients
Renau, AI, Garcia-Vidal, C, Salavert, M
Review. 10.1016/j.riam.2016.02.002. 2016
Last Gasps of the Hepatitis C Virus Dragon: Direct Acting Antiviral Failures and Hepatitis C Virus-Positive Donors
Article. 10.1002/lt.24520. 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Manns, M; (...); SOLAR-2 Investigators
Article. 10.1016/S1473-3099(16)00052-9. 2016
Liver Transplantation for Alcoholic Liver Disease
Addolorato G; (...); Berenguer M
Review. 10.1097/TP.0000000000001156. 2016
Management of infection and febrile neutropenia in patients with solid cancer
Virizuela JA; (...); Cruz JJ
Article. 10.1007/s12094-015-1442-4. 2016
Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease
Bruguera M; (...); Mariño Z
Editorial Material. 10.1016/j.gastrohep.2016.06.003. 2016
Parasitic Infections in Hematopoietic Stem Cell Transplantation.
Article. 10.4084/MJHID.2016.035. 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence
Song AT; (...); Samuel D
Article. 10.3748/wjg.v22.i18.4547. 2016
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence
Montalva EM; (...); Lopez-Andujar R
Article. 10.1016/j.transproceed.2016.07.033. 2016
Reversion of disease manifestations after HCV eradication
van der Meer AJ, Berenguer M
Review. 10.1016/j.jhep.2016.07.039. 2016
Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study
Lopez-Medrano, F; (...); Swiss Transplant Cohort Study STCS
Article. 10.1111/ajt.13735. 2016
The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles
De Pablos, LM; (...); Osuna, A
Article. 10.1038/srep27293. 2016